ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

3.875
-0.50 (-11.43%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -11.43% 3.875 3.75 4.00 4.375 3.625 4.38 4,364,023 14:48:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0447 -0.87 4.46M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 4.38p. Over the last year, Genedrive shares have traded in a share price range of 2.75p to 25.75p.

Genedrive currently has 115,139,946 shares in issue. The market capitalisation of Genedrive is £4.46 million. Genedrive has a price to earnings ratio (PE ratio) of -0.87.

Genedrive Share Discussion Threads

Showing 3651 to 3672 of 25350 messages
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
24/9/2020
16:13
As I said yesterday. When Roger deramps this it flies :)
hooded claw
24/9/2020
16:13
RNS anytime now guys!!!!!
deanmatlazin
24/9/2020
15:55
Have taken a few here today
justtrying1
24/9/2020
15:49
Guys..the saliva test from Genedrive will be announced anytime now. This will be non invasive, cheap with a very quick turnaround with the result.

Once the RNS comes out, the MM will pull the plug and you can hardly buy online. Better to be in now before. Expect a massive upside soon. Buckle up your seat belt!

deanmatlazin
24/9/2020
14:48
Swerves1 - The rise will be massive because the number of issued shares is very low (only 51 million). I would add that colder weather and winter have already arrived; no other sector will prosper better than Covid stocks. Testing will be so scares that I won't be surprised to see Covid shares double or even triple from here. There will be so much demand for testing worldwide that no supplier will be enough. GDR being engaged in many fronts including rapid testing, IMO this is where to be fully invested.
fuji99
24/9/2020
13:27
Fuji99 - I agree. Major news coming from 3 or 4 different angles. Any 1 of these should propel the share price But when all these come in.....the rise is likely to be massive! So am glad to be holding here..,
swerves1
24/9/2020
11:59
Swerves1 - Another big news also due is its development of the Rapid, Portable, point of care test for decentralised SARS-CoV-2 testing since March/April this year - - -
As the global spread of coronavirus infection continues, it is likely that a variety of diagnostic tools will be needed for direct clinical care via specialist laboratories, hospitals and in the community.

It is likely that millions of people will continue to need to be monitored and tested, and high accuracy point of care molecular testing in decentralised settings will play an important role.

genedrive will deliver a clinically verified, robust, easy to use assay that can be used on the Genedrive® instrument in decentralised laboratory settings. - - -

fuji99
24/9/2020
11:25
Exactly......wouldn't like to be out of this when BC validation news lands......or FDA approval......or India orders...Could be a huge rise!
swerves1
24/9/2020
11:23
Good luck to anyone who want to leave. Don't bang your heads against the wall when your realise you made a mistake and now it's too late though...
fuji99
24/9/2020
10:54
No news here for a few weeks by that time will be 90p again
roger148
24/9/2020
10:49
news anytime now. better be in than out. GLA
deanmatlazin
24/9/2020
10:34
If one compares with the August update of GDR Instruction Manual one can see that we have now 2 more companies that approved the methodology: Beckman& Coulter and Cytiva in addition to Qiagen and Macherey-Nagel (from August) . ---
fuji99
24/9/2020
10:01
SP movement is purely artificial. Buy to Sell ratio is 5:1. So the best way to rip the benefits is to be patient and leave it for a short period.
fuji99
24/9/2020
09:55
This is GDR just updated Instruction manual.
fuji99
24/9/2020
09:46
Things are going pretty well with Beckman Coulter, Cytiva and QIAGEN. All three just validated GDR RNA extraction methodology. Check page 3 of attached link: - - -
fuji99
24/9/2020
09:28
110p anyone
roger148
24/9/2020
09:09
buywell is of the opinion that in the wars of the Covid Tests

There can be only one

buywell3
24/9/2020
08:58
In my view this is the only company with huge hopes to produce PCR tests. At present all existing tests are lab tests, not sufficient and taking a long time for the results. GDR is also the only company nearing full approval.
fuji99
24/9/2020
08:51
BC validation news ready to land any moment now……and then should be fireworks here ?!
swerves1
23/9/2020
22:19
Your opinion is ? Yes I agree
hooded claw
23/9/2020
20:48
Overvalued
noreply1
23/9/2020
19:35
It is with great pleasure we share this news. DIVOC Laboratories received NABL certifications and ICMR permission to offer COVID19 testing in our labs. Our NABL certificate is available on request. We are actively looking for partnerships with collection centres to enable offering of COVID19 diagnostic services to our customers.
blackvulture
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock